When to Hire a Device Security Consultant vs. Build In-House

Most medical device manufacturers assume they can solve their cybersecurity problem by hiring a device security consultant or adding a security engineer to the team. Both instincts can be right, but the gap between "we have someone who handles security" and "we have FDA-ready cybersecurity documentation" is wider than most product teams expect - until they're staring at a deficiency letter with a clearance deadline looming.

This article is a decision guide. It covers the real cost of building device security expertise in-house, what a qualified external consultant actually delivers, why FDA submission speed depends on regulatory specialization, how to evaluate and shortlist candidates, and how to scope an engagement with measurable outcomes.

Key Takeaways

• In-house security hires face significant ramp-up for FDA specific knowledge.
• First-year cost for a single in-house expert can exceed $300,000.
• FDA premarket guidance requires specialized documentation expertise.
• Specialized consultants provide submission-ready artifacts immediately.
• A single FDA cyber deficiency can cost more than specialist fees.
• Evaluate consultants on technical depth and FDA regulatory alignment.

Table of Contents

• Key Takeaways
• The real cost of building in-house device security expertise
• What a specialized device security consultant actually delivers
• FDA submission speed and the premarket cybersecurity bottleneck
• How to evaluate and shortlist a medical device cybersecurity consultant
• Scoping the engagement and building your RFP
• Make the decision with the right criteria

Why this matters

The stakes for medical device cybersecurity are higher than ever, driven by the FDA's "Cybersecurity in Medical Devices" Final Guidance dated February 3, 2026. This guidance mandates rigorous premarket and postmarket cybersecurity controls, making the decision between internal expertise and external consultation critical. A single FDA deficiency related to cybersecurity can halt product clearance, incurring significant delays and financial penalties that often far exceed the cost of proactive specialist engagement. Building an in-house team capable of meeting these evolving requirements demands substantial investment not only in salaries and benefits but also in continuous training on standards such as IEC 60601-1-10, ISO 14971, and AAMI TIR57. Achieving the necessary depth of understanding for device architecture, threat modeling, vulnerability management, and regulatory documentation is a sustained effort. External consultants, however, provide immediate access to this specialized knowledge, expediting premarket submissions and ensuring alignment with the FDA's stringent expectations. Their expertise can significantly reduce time to market and mitigate regulatory risks.

The real cost of building in-house device security expertise

The assumption most MedTech teams make is that one strong security hire solves the problem. In practice, securing a connected medical device across hardware, firmware, BLE, cloud integrations, and FDA documentation simultaneously requires a team, a toolchain, and a significant runway of regulatory learning. A single engineer rarely covers all of it, and the costs stack up faster than most budgets anticipate.

Hidden costs beyond a single security salary

In 2026, a senior embedded or firmware security engineer with FDA medical device experience typically commands $150,000 to $200,000 in base salary, with principal-level specialists reaching $200,000 to $250,000. Total employer cost, including benefits, payroll taxes, and overhead, runs roughly 1.2 to 1.4 times that figure. Add specialized tooling: Ghidra for firmware reverse engineering, hardware lab equipment for JTAG and UART interface testing, fuzzing infrastructure, and SBOM management tooling. These investments are not optional for a credible device security program. When you factor in tooling, onboarding time, and ramp costs, the first-year cost of a single qualified hire can easily reach or exceed $300,000 depending on role level and device complexity.

The competency gap that surprises most MedTech teams

Even experienced cybersecurity engineers don't arrive knowing FDA premarket requirements. SPDF documentation, threat modeling mapped to FDA-accepted frameworks, SBOM development in SPDX or CycloneDX format, and eSTAR Section 524B deliverables represent a specialized regulatory language. In practice, engineers from general cybersecurity backgrounds typically need 3 to 6 months of focused effort to reach working independence on standard FDA submissions, and closer to 6 to 12 months for first-time engineers without external regulatory support or a complex device architecture. For most product launch timelines, that ramp period is simply not available. A delayed clearance costs far more than the consulting fees it was meant to avoid.

What a specialized device security consultant actually delivers

A qualified external consultant brings assessment depth and documentation capability that most in-house teams can't match on day one. The scope of a proper engagement goes well beyond a vulnerability scan and a report. It covers the full device attack surface and produces the specific artifacts that move a program forward.

The full assessment scope across the device stack

A thorough device security assessment covers hardware interfaces including JTAG, UART, and SPI; firmware extraction and static analysis; BLE, RF, and wireless protocol testing; cloud and API review; mobile app assessment; and boot chain validation. A quality consultant doesn't stop at findings. They produce a risk register, a threat model with attack scenarios mapped to real evidence, a prioritized remediation roadmap with owner assignments, and an executive summary with severity ratings. The deliverable set should be specific enough that your engineering team can act on it immediately rather than interpret it. Some deliverables, such as retest cycles and source code review, may require separate contracting depending on the engagement scope. For a broader reference on IoT and embedded device testing principles, see the OWASP IoT Security Testing Guide.

Typical engagement timelines and pricing benchmarks

Before contacting vendors, it helps to have realistic budget anchors. Standard firmware and hardware security consultant engagements run $15,000 to $40,000 for focused assessments, with lightweight scoping packages available from $5,000 to $15,000 for early-stage teams. Deep technical assessments with full threat modeling for a regulated device range from $50,000 to $150,000 or more. Monthly advisory retainers for ongoing support sit between $8,000 and $20,000. For commercial launch prep on a connected device, budget $25,000 to $60,000 as a working planning number. These ranges reflect the complexity of the work and the regulatory experience required, not just hours billed. Actual costs vary by region, device complexity, and the depth of FDA documentation required.

FDA submission speed and the premarket cybersecurity bottleneck

The FDA's February 2026 Final Premarket Cybersecurity Guidance, combined with FD&C Act Section 524B, makes cybersecurity documentation a hard submission gate. Missing or weak artifacts don't just draw comments - they generate deficiency letters that delay clearance by months and sometimes require complete rework of the submission package. For legal analysis of the guidance and its implications for premarket submissions, see this DLA Piper briefing on the revised premarket submission guidance.

Why generalist consultants create submission risk

An IoT security consulting firm without FDA experience can produce technically sound testing work and still generate documentation that FDA reviewers reject. Typical gaps include threat models not mapped to FDA-accepted frameworks, SBOMs missing machine-readable format requirements, SPDF documentation that doesn't align with QMSR language, and postmarket plans that don't address coordinated vulnerability disclosure requirements. Each of these gaps can trigger a deficiency letter on its own. The NIST SP 800-213 series on IoT device cybersecurity is a useful reference for mapping device controls across the lifecycle. The cost of a single FDA cybersecurity deficiency letter response, in consulting fees, internal time, and delayed revenue, can outweigh the price difference between a generalist and a specialist engagement. That math should drive the sourcing decision more than hourly rates.

How a device security consultant with FDA specialization compresses timelines

What separates a medical device cybersecurity consultant from a generalist IoT security firm is the ability to deliver a complete, submission-ready package under the February 2026 FDA guidance without requiring extensive back-and-forth. A qualified firm at this level produces SPDF documentation, a threat model tied to FDA-accepted methodology, SBOM development in SPDX or CycloneDX, security architecture views, and eSTAR-ready Section 524B documentation as standard deliverables, not add-ons. Blue Goat Cyber is built specifically for this work. With a track record spanning 250+ FDA submissions and no cyber-related deficiency letters across that portfolio, our premarket packages are scoped to fit regulated device timelines and structured to meet current FDA documentation standards. That kind of documented, submission-specific experience is what you should be evaluating when comparing firms, not generic security credentials. See Securing Medical Devices: The Key to Faster FDA Approval and Investor Confidence for practical examples of how security work accelerates approvals and supports investor conversations.

How to evaluate and shortlist a medical device cybersecurity consultant

Once you've decided external consulting is the right move, the next challenge is separating strong candidates from firms that look credible on a website but lack the specific experience your submission requires. The evaluation criteria that matter most are technical depth and FDA regulatory alignment, in that order.

Technical skills and certifications worth requiring

Prioritize demonstrated experience over paper credentials. The skills that matter are hands-on firmware reverse engineering with tools like Ghidra or IDA, hardware interface testing across JTAG, UART, and SWD, wireless protocol security covering BLE, Zigbee, and MQTT, and cryptography and key management in constrained environments. A device cybersecurity consultant's value shows in their portfolio, not their certifications list. Certifications like CISSP or GIAC are useful signals but secondary to a verifiable portfolio of completed embedded device assessments. Ask directly: "Show me a real finding from an embedded medical device engagement and walk me through how it was remediated." Firms that answer specifically are worth continuing with. Firms that pivot to slide decks and methodology overviews probably aren't.

FDA regulatory alignment: the questions that separate specialists from generalists

See also: 510(k) Cybersecurity Deficiencies That Trigger FDA Holds, Infusion Pump Cybersecurity: FDA Expectations in 2026, and Medical Device Incident Response Plan: FDA Expectations 2026.

Use these five questions to run a fast filter on any candidate:

• "How do you map threat modeling outputs to the FDA's premarket guidance, and which framework do you use?"
• "How do you structure SPDF documentation for eSTAR submissions?"
• "Have you responded to an FDA cybersecurity deficiency letter, and what was the outcome?"
• "What SBOM format do you deliver, and does it meet machine-readable requirements under Section 524B?"
• "How do you align postmarket vulnerability handling plans with FDA coordinated disclosure expectations?"

A generalist IoT security consulting firm will hesitate, give vague answers, or ask follow-up questions about what the FDA requires. A medical device cybersecurity specialist will answer immediately and specifically. That response quality tells you more than any credentials document.

Scoping the engagement and building your RFP

A well-scoped engagement protects your budget, gives you measurable outcomes, and forces the vendor to commit to specifics before the work begins. Vague scope documents produce vague deliverables, and vague deliverables don't support FDA submissions.

Defining deliverables and measurable outcomes

A solid scope document should require a named vulnerability report with severity ratings and proof-of-concept evidence, a prioritized remediation roadmap with owner assignments, a threat model tied to FDA-accepted methodology, an SBOM in SPDX or CycloneDX format, and a defined retest cycle after remediation is complete. When requesting SBOMs, specify the format explicitly - SPDX and CycloneDX are the machine-readable standards FDA reviewers expect under Section 524B. If the consultant won't commit to deliverable format and depth in writing, that's a red flag worth acting on before you sign anything. "Security assessment" as a line item in a contract is not a deliverable. It's a description of effort with no accountability attached.

Choosing the right engagement model for your stage

Match the model to your lifecycle position. Early-stage companies preparing a first FDA submission benefit most from a fixed-fee premarket package with a defined deliverable set and a timeline that fits your regulatory calendar. Teams in active development need a monthly advisory retainer with defined hours and clear escalation protocols. Companies managing a cleared device fleet need ongoing SBOM maintenance, vulnerability monitoring, patch validation, and postmarket coordination.

Budget planning benchmarks: $25,000 to $60,000 for commercial launch prep; $50,000 to $150,000 or more for a complex regulated device with full FDA documentation; $8,000 to $20,000 per month for ongoing postmarket support. Whether you're engaging a firmware security consultant for a focused assessment or a full-service medical device cybersecurity consultant for a complete premarket package, matching scope to stage keeps costs predictable and outcomes measurable.

The difference between a delayed launch and a first-pass FDA clearance often comes down to whether your device security consultant has completed this exact submission type before, on a device like yours, under current guidance. That specificity is what you're actually buying.

Make the decision with the right criteria

Building in-house device security expertise rarely covers FDA submission requirements at the depth and speed a product launch demands. Generalist IoT security consultants miss the premarket documentation specifics that drive clearance. Specialized medical device cybersecurity consultants pay for themselves when they prevent a single deficiency letter, and they pay for themselves several times over when they compress your clearance timeline by months.

The checklist is straightforward. Define deliverables before you sign. Verify FDA regulatory experience with direct questions. Require a portfolio of real findings from similar devices. Choose an engagement model that matches your current stage. Don't accept "we've done medical device work" as a qualifier - ask for the submission pathway, the device class, and the outcome.

If you're preparing an FDA premarket submission and need a device security consultant with a documented track record spanning 250+ FDA submissions and no cyber-related deficiency letters, Blue Goat Cyber is built specifically for that engagement. Our premarket packages are structured to meet current FDA documentation standards, with turnaround timelines scoped to regulated device schedules. For practical planning and launch guidance, see Why Your Medical Device Go-to-Market Strategy Should Include Cybersecurity, and for a list of common submission pitfalls review 12 Reasons the FDA Rejects Medical Device Cybersecurity Submissions.

FAQ

What signals that we should hire a consultant instead of building in-house?

An imminent 510(k), De Novo, or PMA submission; no in-house FDA cybersecurity submission experience; a device portfolio of one or two products rather than ten; and a need for clearance on a quarterly milestone rather than an open-ended timeline. In all four cases, a specialized consultant is usually faster and cheaper than a 6-12 month internal ramp.

What does a fully loaded in-house device security hire actually cost?

Salary is only one line. Add benefits, the toolchain (SAST, SCA, DAST, threat-modeling, SBOM, fuzz), training, conference and certification budgets, and the regulatory ramp - someone new to MedTech typically needs 6-12 months before they are productive against an FDA submission. Most teams underestimate the loaded cost by 2-3x.

How is a specialized MedTech consultant different from a generalist IoT or AppSec consultant?

A specialist writes deliverables in the FDA's expected shape: threat models referencing AAMI TIR57, SBOMs in SPDX or CycloneDX, pen test reports mapped to Section 524B, and SPDF evidence packages reviewers recognize. Generalist IoT or AppSec consultants often produce technically sound work that still gets rejected because the format and references do not match what the FDA expects.

How should we structure the RFP for a MedTech security consulting engagement?

Define the device class and pathway (510(k), De Novo, PMA), the submission date, the testing scope (interfaces, protocols, cloud), the required deliverables (threat model, SBOM, VEX, pen test report, SPDF evidence), and the standards to reference. Ask for two prior anonymized FDA deliverables as work samples. Avoid hourly engagements for submissions - fixed-scope is what compresses timelines.

What questions separate qualified consultants from unqualified ones?

Ask how many FDA cybersecurity deficiency letters they have responded to, which standards they cite by default in threat models, whether they produce SBOMs in SPDX or CycloneDX (and why), how they handle VEX, and what their typical timeline is from kickoff to submission-ready package. Vague answers are a signal.

Can we hybrid - keep some work in-house and outsource the rest?

Often the strongest model. Keep secure coding, SAST, SCA, and fuzz testing in engineering. Outsource the threat model, the external pen test, the SBOM/VEX production, and the SPDF evidence package for the submission itself. That keeps internal cost manageable while still getting clearance-grade deliverables.

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.

How Blue Goat approaches this

Blue Goat Cyber helps medical device manufacturers navigate the complexities of FDA cybersecurity mandates. Our approach focuses on delivering actionable, FDA-ready documentation and technical assessments without the overhead of building a specialized internal team from scratch. Our consultants, many with CISSP and OSCP certifications and backgrounds in ex-military red teams, apply deep technical knowledge to threat modeling, penetration testing, and security architecture reviews. We accelerate your premarket submission process by providing immediate access to expertise in regulatory compliance, translating technical findings into the specific artifacts required by the FDA. This direct engagement avoids lengthy hiring cycles and training programs. If the FDA raises cybersecurity deficiencies after our submission, we resolve them at no additional cost. Learn more about our specialized support for /services/fda-premarket-cybersecurity-services.